Proteomics Market Report 2018| Size, Shares, Growth, Analysis and Forecast 2022

1. Opportunity Analysis and Industry Forecast, 2016-2023 Proteomics Market Report 2018| Size, Shares, Growth, Analysis and Forecast 2022 Global Opportunity Analysis and Industry Forecast, 2016-2023

2. PROTEOMICS MARKET Proteomics Market Report, published by Allied Market Research, forecasts that the global market is expected to garner $44,452 million by 2022, registering a CAGR of 13.7% during the period 2014 - 2022.Instruments segment is expected to dominate the global market throughout the forecast period. North America held the leading position in the global market in 2015, and is expected to maintain this trend. Proteomics is used to evaluate the rate of protein production, interaction of proteins with one another, involvement of proteins in metabolic pathways, and modification of proteins. In addition, it finds extensive applications in drug discovery, development of personalized medicines, and identification of markers for disease diagnosis, which has led to the stellar growth of the proteomics market in the past few years. With the increase in awareness regarding the benefits of personalized medicines, companies and government organizations have increased their R&D expenditure on the development of proteomics. As per the proteomics market research report, it is estimated that reagents segment will continue to lead the overall market during the forecast period.

3. PROTEOMICS MARKET Personalized medicine is a new and better approach to healthcare based on each person's unique genetic makeup. In personalized medicine, diagnostic testing is often employed to select appropriate and optimal therapies based on the context of a patient’s genetic content or other molecular & cellular analysis. Personalized medicine finds extensive applications in the diagnosis and treatment of cancer. Proteomics is an emerging field that can make unique contributions to the field of personalized medicines. It has the advantage over genomics-based assays as it offers direct examination of the molecular machinery of cell physiology, including protein expression, sequence variations & isoforms, posttranslational modification, and protein‐protein complexes. Advances in proteomic technologies have made important contribution to the development of personalized medicine by facilitating detection of protein biomarkers, proteomics-based molecular diagnostics, as well as protein biochips & pharmacoproteomics. For instance, NantHealth, Inc. launched Genomic Proteomic Spectrometry Cancer, or GPS Cancer, which is a comprehensive molecular test that measures the proteins present in the patient’s tumor tissue, combined with whole genomic and transcriptomic sequencing of tumor and normal samples. As proteomics have important contribution in the field of personalized medicine, the impact of the driver is expected to increase during the study period with the increase in popularity of the use of personalized medicines in the treatment of cancer and neurodegenerative diseases.

4. PROTEOMICS MARKET Technological advancements to drive the proteomics market The recent technological advancements in the field of proteomics is expected to spur the proteomics market. These advancements attract the interest of pharmaceutical & biotechnology companies to venture in the field of proteomics as the convenience of use of the instrument and the outcome of the procedure have improved. For instance, technological advancements such as increased resolution of mass spectrometry helps to extract more information from minimal amount of sample. Similarly, dual mass analyzers such as LC/MS, GC/MS, FT-MS, and MALDI-TOF/TOF help to provide more detailed information about protein structure. Moreover, the development of improved liquid chromatography and gel electrophoresis have significantly helped in the protein identification and separation methods. Two-dimensional gel electrophoresis, which is based on isoelectric focusing (IEF) and denaturing polyacrylamide gel matrix for protein separation, have also been developed by scientist recently. These technological advancements are expected to propel the proteomics market. Download Free Sample Report: https://www.alliedmarketresearch.com/request-sample/1677

5. PROTEOMICS MARKET Proteomics enables the study of proteomes (the entire complement of proteins that is or can be expressed by a cell, tissue, or organism) as well as their interactions. Moreover, it characterizes protein expression profiles and identifies protein structures, localizations, activities, modifications, and interactions in physiological or pathological states. As proteins perform most biological functions, proteomics bridges the gap between the information coded in the genome sequence and cellular behavior. For instance, hepatocellular carcinoma is the third leading cause of death globalwide. Chemotherapeutic treatment is ineffective against hepatocellular carcinoma (HCC); hence, surgical removal or liver transplantation is the only treatment possible. Proteomics studies of HCC may decode the mechanisms of HCC initiation and progression, and it also has the potential to discover novel diagnostic biomarkers and therapeutic targets.

6. PROTEOMICS MARKET Top Impacting Factors

7. PROTEOMICS MARKET

8. PROTEOMICS MARKET • Key Findings Of Proteomics Market • The instrument segment generated the highest revenue in 2015, and is projected to grow at a CAGR of 14.6% during the forecast period. • Protein microarrays segment occupied about half of the total proteomics instrument market share in 2015, while the spectrometry segment was the second leading segment. • Drug discovery dominated the global proteomics applications market in 2015 accounting for about two-third of the market in 2015. • In the year 2015, the U.S. was the leading country in the global proteomics market, accounting for about one-third share of the overall market. • Germany held about one-fourth share of the European proteomics market in 2015. • Indian proteomics market is expected to grow at a CAGR of 20.3%.

9. PROTEOMICS MARKET North America held the largest share of about two-fifth of the market in 2015. The increase in popularity and adoption of personalized medicines and favorable government funding and initiatives are the key factors that drive the market growth in this region. However, Asia-Pacific is expected to grow at a CAGR of 17.0% from 2016 to 2022. The rise in prevalence of chronic diseases and increase in interest of researchers to utilize proteomics in the disease diagnosis and treatment are expected to fuel the market growth. Key players profiled in this report include Thermo Fisher Scientific Corporation, Agilent Technologies, Luminex Corporation, Danaher Corporation, Inc., Bio-Rad Laboratories, Inc., GE Healthcare, Waters Corporation, Caprion Proteomics, Inc., PerkinElmer, Inc., and Bruker Corporation. Do Purchase Report: https://www.alliedmarketresearch.com/purchase-enquiry/1677

10. PROTEOMICS MARKET Contact: Shriram Dighe 5933 NE Win Sivers Drive #205, Portland, OR 97220 United States Toll Free: +1-800-792-5285 UK: +44-845-528-1300 Hong Kong: +852-301-84916 India (Pune): +91-20-66346060 Fax: +1⟨855⟩550-5975help@alliedmarketresearch.com Web: https://www.alliedmarketresearch.com

11. PROTEOMICS MARKET Thank You! For More Details Visit us at https://www.alliedmarketresearch.com Follow Us On